Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · IEX Real-Time Price · USD
5.40
-0.23 (-4.09%)
At close: Jul 19, 2024, 4:00 PM
5.28
-0.12 (-2.22%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Nanobiotix Revenue

In the year 2023, Nanobiotix had annual revenue of $40.23M with 691.80% growth.

Revenue (ttm)
$40.23M
Revenue Growth
+691.80%
P/S Ratio
6.32
Revenue / Employee
$394,412
Employees
102
Market Cap
254.40M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202340.23M35.15M691.80%
Dec 31, 20225.08M2.07M68.91%
Dec 31, 20213.01M-55.46K-1.81%
Dec 31, 20203.06M208.36K7.30%
Dec 31, 20192.86M-1.14M-28.60%
Dec 31, 20184.00M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 959.44M
AirSculpt Technologies 197.72M
Nektar Therapeutics 90.17M
Codexis 74.23M
Sanara MedTech 68.00M
AVITA Medical 51.50M
Zevra Therapeutics 28.01M
Profound Medical 5.33M
Revenue Rankings